Literature DB >> 32484860

Clinical Performance of the Roche SARS-CoV-2 Serologic Assay.

Mei San Tang1, Karl G Hock1, Nicole M Logsdon2, Jennifer E Hayes2, Ann M Gronowski1, Neil W Anderson1, Christopher W Farnsworth1.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; serology

Mesh：

Substances：

Year:  2020        PMID： 32484860      PMCID： PMC7314243          DOI： 10.1093/clinchem/hvaa132

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  19 in total

1.  Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2.

Authors:  Raymond T Suhandynata; Melissa A Hoffman; Deli Huang; Jenny T Tran; Michael J Kelner; Sharon L Reed; Ronald W McLawhon; James E Voss; David Nemazee; Robert L Fitzgerald
Journal:  Clin Chem       Date:  2021-01-30       Impact factor: 8.327

2.  SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.

Authors:  Marie-Luise Buchholtz; Florian M Arend; Peter Eichhorn; Michael Weigand; Alisa Kleinhempel; Kurt Häusler; Mathias Bruegel; Lesca M Holdt; Daniel Teupser
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

3.  Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain.

Authors:  Chao Wu; Abraham J Qavi; Asmaa Hachim; Niloufar Kavian; Aidan R Cole; Austin B Moyle; Nicole D Wagner; Joyce Sweeney-Gibbons; Henry W Rohrs; Michael L Gross; J S Malik Peiris; Christopher F Basler; Christopher W Farnsworth; Sophie A Valkenburg; Gaya K Amarasinghe; Daisy W Leung
Journal:  iScience       Date:  2021-06-01

4.  Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.

Authors:  Martin Risch; Myriam Weber; Sarah Thiel; Kirsten Grossmann; Nadia Wohlwend; Thomas Lung; Dorothea Hillmann; Michael Ritzler; Francesca Ferrara; Susanna Bigler; Konrad Egli; Thomas Bodmer; Mauro Imperiali; Yacir Salimi; Felix Fleisch; Alexia Cusini; Harald Renz; Philipp Kohler; Pietro Vernazza; Christian R Kahlert; Matthias Paprotny; Lorenz Risch
Journal:  Biomed Res Int       Date:  2020-11-16       Impact factor: 3.411

5.  Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.

Authors:  Amin Addetia; Katharine H D Crawford; Adam Dingens; Haiying Zhu; Pavitra Roychoudhury; Meei-Li Huang; Keith R Jerome; Jesse D Bloom; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

6.  Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection.

Authors:  Kyra Y L Chua; Sara Vogrin; Intissar Bittar; Jennifer H Horvath; Hari Wimaleswaran; Jason A Trubiano; Natasha E Holmes; Que Lam
Journal:  Pathology       Date:  2020-09-21       Impact factor: 5.306

7.  Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia.

Authors:  Julien Favresse; Christine Eucher; Marc Elsen; Carlos Graux; Paul Goebels; Kim Laffineur; Jean-Baptiste Nicolas; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Br J Haematol       Date:  2020-07-09       Impact factor: 8.615

8.  Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate.

Authors:  Amin Addetia; Katharine Hd Crawford; Adam Dingens; Haiying Zhu; Pavitra Roychoudhury; Meei-Li Huang; Keith R Jerome; Jesse D Bloom; Alexander L Greninger
Journal:  medRxiv       Date:  2020-08-14

9.  Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodies.

Authors:  Nguyen N Nguyen; Manohar B Mutnal; Richard R Gomez; Huy N Pham; Lam T Nguyen; William Koss; Arundhati Rao; Alejandro C Arroliga; Liping Wang; Dapeng Wang; Yinan Hua; Priscilla R Powell; Li Chen; Colin C McCormack; Walter J Linz; Amin A Mohammad
Journal:  PLoS One       Date:  2020-10-06       Impact factor: 3.240

10.  SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection.

Authors:  Massimo Pieri; Marco Ciotti; Nicoletta Carlozzi; Maria Loredana Frassanito; Arianna Meloni; Alessandro Cistera; Giordano Turchetti; Silvia Niscola; Giuseppe Labate; Graziella Calugi; Sergio Bernardini
Journal:  Clin Chim Acta       Date:  2020-09-28       Impact factor: 3.786
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.